WuXi Biologics

Activities: Drug Delivery Pharmaceutical

Trending Articles

  1. Integrity testing of HEPA filters: A practical approach Filtering the air in aseptic process areas is critical to maintaining the cleanliness of the production environment. Jesus Casas provides tips to ensure HEPA filters are fit...
  2. Nortek Air Solutions CleanSpace relaunches SERVICOR for modular cleanrooms Nortek Air Solutions CleanSpace shared with Cleanroom Technology how SERVICOR for modular cleanrooms, complies with ANNEX 1 requirements, as it was relaunched to meet industry...
  3. Elemental Machines launches new cleanroom alerting and monitoring product The lab connectivity specialist has launched a new product, which introduces three features to the Elemental Machines’ Dashboard, specifically built with cleanrooms in mind
  4. When to Replace your HEPA Filter – According to a Cleanroom Expert One of the most crucial elements in operating clean and sterile rooms is the use of HEPA filters, which are effective in capturing particles of almost all sizes. However, over...
  5. What is ISO 8 cleanroom classification? Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

Related Content

Pharmaceutical

WuXi Biologics plans to build a comprehensive CRDMO centre in Singapore

This investment will establish a cutting-edge, fully integrated CRDMO centre in Singapore and strenghten WuXi Biologics’ global research, development and manufacturing network
Design & Build

WuXi Biologics closes deal to build biomanufacturing hub in the US

China-based WuXi Biologics has agreed to build its 107,000 sqft clinical and commercial manufacturing facility in Worcester, US
Design & Build

WuXi completes weather-tight seal of Irish biologics facility

WuXi Biologics has completed the seal of its first global supply facility in Europe that began construction in February 2019
Design & Build

WuXi invests $240m in Irish CDMO operations

WuXi Vaccines, a subsidiary of China-based WuXi Biologics, will spend $240m to build a dedicated vaccine manufacturing facility
Design & Build

WBDC demolishes hospital for WuXi potential biomanufacturing centre

Worcester Business Development Corp has received $15m from the state to demolish the 380,000 sqft section of a vacant hospital in Massachusetts
Manufacturing

WuXi Biologics CEO: Vaccine CDMO is the next area of growth

Dr Chris Chen launches WuXi Vaccines, announces new facility and a 20-year manufacturing contract worth US$3 billion
Research & Development

Swiss NBE-Therapeutics chooses WuXi Biologics as manufacturing partner

Chinese-Swiss partnership will focus on development and manufacturing capacity of immune-stimulatory ADC treatment against the ROR1 cancer target
Subscribe now